Published in Cardiovasc Drugs Ther on November 01, 1993
The activities of fructose 1,6-diphosphatase, phosphofructokinase and phosphoenolpyruvate carboxykinase in white muscle and red muscle. Biochem J (1967) 3.14
Beta-blockers for hypertension. Cochrane Database Syst Rev (2007) 2.91
Effects of insulin on the pattern of glucose metabolism in the perfused working and Langendorff heart of normal and insulin-deficient rats. Biochem J (1969) 2.46
South African hypertension guideline 2006. S Afr Med J (2006) 2.23
Sudden death and sport. Lancet (1975) 2.14
Effects of increased heart work on glycolysis and adenine nucleotides in the perfused heart of normal and diabetic rats. Biochem J (1971) 2.04
Effects of glucose and fatty acids on myocardial ischaemia and arrhythmias. Lancet (1994) 1.99
Drugs and the heart. III. Calcium antagonists. Lancet (1980) 1.99
Atenolol plus nifedipine for mild to moderate systemic hypertension after fixed doses of either agent alone. Am J Cardiol (1986) 1.75
Relation between plasma free fatty acids and arrhythmias within the first twelve hours of acute myocardial infarction. Lancet (1983) 1.69
Glucose-insulin-potassium (GIK) for acute myocardial infarction: a negative study with a positive value. Cardiovasc Drugs Ther (1999) 1.63
Nifedipine and mortality. Grave defects in the dossier. Circulation (1995) 1.61
Adverse interaction between nifedipine and beta-blockade. Br Med J (1980) 1.60
Metabolism of the heart in health and disease. I. Am Heart J (1968) 1.58
Calcium antagonists. Mechanisms, therapeutic indications and reservations: a review. Q J Med (1984) 1.43
Increased plasma-free-fatty-acid concentrations and their significance in patients with acute myocardial infarction. Lancet (1969) 1.43
Effects of glucose, insulin and potassium infusion on tissue metabolic changes within first hour of myocardial infarction in the baboon. Circulation (1975) 1.39
Protons in ischemia: where do they come from; where do they go to? J Mol Cell Cardiol (1991) 1.39
Effect of oxygenation and consequent pH changes on the efficacy of St. Thomas' Hospital cardioplegic solution. J Thorac Cardiovasc Surg (1991) 1.39
Myocardial blood flow, deoxyglucose uptake, and myocyte viability in ischemia. J Nucl Med (1992) 1.38
Characterization of the "border zone" in acute regional ischemia in the dog. Am J Cardiol (1977) 1.28
Antihypertensive effects of nifedipine combined with cardioselective beta-adrenergic receptor antagonism by atenolol. Am Heart J (1982) 1.28
Metabolism of free fatty acids, glucose and catecholamines in acute myocardial infarction. Relation to myocardial ischemia and infarct size. Am J Cardiol (1975) 1.25
Drugs and the heart. VI. Vasodilating drugs. Lancet (1980) 1.23
Drugs and the heart. Lancet (1980) 1.21
Is a high glycogen content beneficial or detrimental to the ischemic rat heart? A controversy resolved. Circ Res (1996) 1.19
Biochemical aspects of arrhythmogenesis and ventricular fibrillation. Am J Cardiol (1979) 1.18
Modulation of severity of reperfusion stunning in the isolated rat heart by agents altering calcium flux at onset of reperfusion. Circ Res (1992) 1.18
Metabolic response during impending myocardial infarction. I. Relevance of studies of glucose and fatty acid metabolism in animals. Circulation (1972) 1.18
Coronary flow rate and perfusion pressure as determinants of mechanical function and oxidative metabolism of isolated perfused rat heart. J Physiol (1965) 1.16
Effects of substrates on tissue metabolic changes in the isolated rat heart during underperfusion and on release of lactate dehydrogenase and arrhythmias during reperfusion. Circ Res (1978) 1.16
Protective action of amiodarone against ventricular fibrillation in the isolated perfused rat heart. Am J Cardiol (1979) 1.13
Reduction of ischemic K+ loss and arrhythmias in rat hearts. Effect of glibenclamide, a sulfonylurea. Circ Res (1990) 1.13
Myocardial metabolism in ischemic heart disease: basic principles and application to imaging by positron emission tomography. Prog Cardiovasc Dis (1989) 1.13
Metabolism of triglyceride fatty acid by the perfused rat heart. Biochem J (1967) 1.12
Pyruvate metabolism in the perfused rat heart. Am J Physiol (1963) 1.11
Adenosine cardioplegia. Adenosine versus potassium cardioplegia: effects on cardiac arrest and postischemic recovery in the isolated rat heart. J Thorac Cardiovasc Surg (1989) 1.09
The value of lactate and pyruvate measurements in the assessment of the redox state of free nicotinamide-adenine dinucleotide in the cytoplasm of perfused rat heart. Eur J Clin Invest (1971) 1.07
Dinitrophenol, cyclosporin A, and trimetazidine modulate preconditioning in the isolated rat heart: support for a mitochondrial role in cardioprotection. Cardiovasc Res (2000) 1.07
Effects of free fatty acid and enzyme release in experimental glucose on myocardial infarction. Nature (1975) 1.07
Glucose flux rate regulates onset of ischemic contracture in globally underperfused rat hearts. Circ Res (1990) 1.07
Glucose and glycogen utilisation in myocardial ischemia--changes in metabolism and consequences for the myocyte. Mol Cell Biochem (1998) 1.07
Cyclic AMP levels in ischaemic and non-ischaemic myocardium following coronary artery ligation: relation to ventricular fibrillation. J Mol Cell Cardiol (1978) 1.06
Calcium channel blockers and preconditioning. J Mol Cell Cardiol (2000) 1.06
The inhibition of skeletal-muscle fructose 1,6-diphosphatase by adenosine monophosphate. Biochem J (1967) 1.06
Drugs and the heart four years on. Lancet (1984) 1.05
Ventricular arrhythmias associated with coronary artery occlusion and reperfusion in the isolated perfused rat heart: a model for assessment of antifibrillatory action of antiarrhythmic agents. Cardiovasc Res (1978) 1.04
Experimental myocardial infarction with left ventricular failure in the isolated perfused rat heart. Effects of isoproterenol and pacing. J Mol Cell Cardiol (1975) 1.04
Effect of fatty acids on contractility and rhythm of the heart. Nature (1970) 1.03
Role of cyclic nucleotides in heart metabolism. Cardiovasc Res (1982) 1.02
A relationship between adenosine triphosphate, glycolysis and ischaemic contracture in the isolated rat heart. J Mol Cell Cardiol (1981) 1.02
Drugs and the heart. IV. Antiarrhythmic agents. Lancet (1980) 1.01
The effect of alpha- and beta-adrenoceptor antagonist agents on reperfusion ventricular fibrillation and metabolic status in the isolated perfused rat heart. J Am Coll Cardiol (1983) 0.99
Is lactate-induced myocardial ischaemic injury mediated by decreased pH or increased intracellular lactate? J Mol Cell Cardiol (1995) 0.99
Myocardial infarct size. Part I. Basic considerations. Am Heart J (1980) 0.98
A role for the RISK pathway and K(ATP) channels in pre- and post-conditioning induced by levosimendan in the isolated guinea pig heart. Br J Pharmacol (2008) 0.98
Cyclic adenosine monophosphate, ventricular fibrillation, and antiarrhythmic drugs. Lancet (1976) 0.96
Failure of high concentrations of circulating free fatty acids to provoke arrhythmias in experimental myocardial infarction. Lancet (1971) 0.96
Myocardial infarct size. Part 2. Comparison of anti-infarct effects of beta-blockade, glucose-insulin-potassium, nitrates, and hyaluronidase. Am Heart J (1980) 0.96
Opposing effects on infarction of delta and kappa opioid receptor activation in the isolated rat heart: implications for ischemic preconditioning. Basic Res Cardiol (2000) 0.95
Impaired cardiac work and oxygen uptake after reperfusion of regionally ischaemic myocardium. J Mol Cell Cardiol (1979) 0.94
Distribution of myocardial blood flow before and after coronary artery ligation in the baboon. Relation to early ventricular fibrillation. Cardiovasc Res (1974) 0.94
Adrenaline-induced "oxygen-wastage" and enzyme release from working rat heart. Effects of calcium antagonism, beta-blockade, nicotinic acid and coronary artery ligation. J Mol Cell Cardiol (1979) 0.94
Catecholamine-induced myocardial cell damage: catecholamines or adrenochrome. J Mol Cell Cardiol (1985) 0.93
Effect of alpha-adrenoceptor antagonists (phentolamine, nicergoline and prazosin) on reperfusion arrhythmias and noradrenaline release in perfused rat heart. Br J Pharmacol (1985) 0.93
Computer simulation of metabolism of glucose-perfused rat heart in a work-jump. Am J Physiol (1982) 0.92
Effect of early oral feeding on plasma free fatty acid concentrations in patients in a coronary care unit. Br Heart J (1975) 0.92
Effect of glucose-insulin-potassium infusions on arteriovenous differences of glucose of free fatty acids and on tissue metabolic changes in dogs with developing myocardial infarction. Am J Cardiol (1976) 0.92
Significance of release of adenosine triphosphate and adenosine induced by hypoxia or adrenaline in perfused rat heart. J Mol Cell Cardiol (1987) 0.92
Delta opioid receptor stimulation mimics ischemic preconditioning in human heart muscle. J Am Coll Cardiol (2000) 0.91
Effects of components of ischemia and metabolic inhibition on delayed afterdepolarizations in guinea pig papillary muscle. Circ Res (1987) 0.91
Effect of glucose-insulin-potassium infusions on epicardial ECG changes and on myocardial metabolic changes after coronary artery ligation in dogs. Cardiovasc Res (1981) 0.91
Letter: Heart disease in marathon runners. N Engl J Med (1976) 0.91
Effect of increased aortic perfusion pressure on fluorescent emission of the isolated rat heart. J Mol Cell Cardiol (1974) 0.90
Drugs and the heart. V. Digitalis and sympathomimetic stimulants. Lancet (1980) 0.89
Influence of propranolol isomers and atenolol on myocardial cyclic AMP, high energy phosphates and vulnerability to fibrillation after coronary artery ligation in the isolated rat heart. Cardiovasc Res (1981) 0.89
The heart in diabetes mellitus. Part II. Acute myocardial infarction and diabetes. S Afr Med J (1979) 0.89
Catecholamine-mediated arrhythmias in acute myocardial infarction. Experimental evidence and role of beta-adrenoceptor blockade. S Afr Med J (1979) 0.89
Propranolol and experimental myocardial infarction: substrate effects. Postgrad Med J (1976) 0.89
The role of cyclic adenosine monophosphate in adrenergic effects on ventricular vulnerability to fibrillation in the isolated perfused rat heart. J Clin Invest (1978) 0.89
International Society and Federation of Cardiology: Working Group on Classification of Calcium Antagonists for Cardiovascular Disease. Am J Cardiol (1987) 0.88
Relation of cyclic nucleotide ratios to ischemic and reperfusion injury in nitric oxide-donor treated rat hearts. J Cardiovasc Pharmacol (2001) 0.88
Increased coronary venous inorganic phosphate concentrations during experimental myocardial ischemia. Am J Cardiol (1972) 0.88
Comparison of respiratory effects of two cardioselective beta-blockers, celiprolol and atenolol, in asthmatics with mild to moderate hypertension. Chest (1989) 0.88
Defective oxidative phosphorylation in hereditary myocardiopathy in the Syrian hamster. Cardiovasc Res (1968) 0.87
Letter: Marathon runners and impending heart-attacks. Lancet (1976) 0.87
Potential arrhythmogenic role of cyclic adenosine monophosphate (AMP) and cytosolic calcium overload: implications for prophylactic effects of beta-blockers in myocardial infarction and proarrhythmic effects of phosphodiesterase inhibitors. J Am Coll Cardiol (1992) 0.87
Role of carnitine in fatty acid metabolism of normal and ischemic myocardium. Am Heart J (1979) 0.87
Calcium and catecholamines: relevance to cardiomyopathies and significance in therapeutic strategies. J Mol Cell Cardiol (1985) 0.86
Proposed metabolic vicious circle in patients with large myocardial infarcts and high plasma-free-fatty-acid concentrations. Lancet (1977) 0.86
Tumor necrosis factor in myocardial hypertrophy and ischaemia--an anti-apoptotic perspective. Cardiovasc Res (2000) 0.86
Ryanodine and caffeine prevent ventricular arrhythmias during acute myocardial ischemia and reperfusion in rat heart. Circ Res (1988) 0.86
High mortality in obese women diabetics with acute myocardial infarction. Br Med J (1977) 0.86
The oxidation and subcellular distribution of 14 C-palmitate in experimental acute myocardial infarction. Cardiology (1971) 0.86
Hemodynamic effects of sublingual nifedipine in acute myocardial infarction. Am J Cardiol (1984) 0.86
Sodium-potassium cotransport activity as genetic marker in essential hypertension. Br Med J (Clin Res Ed) (1982) 0.86
Regional myocardial ischemia: characterization of temporal, transmural and lateral flow interfaces in the porcine heart. Can J Cardiol (1986) 0.86